1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Enzyme Replacement Therapy Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Enzyme Replacement Therapy Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Enzyme Replacement Therapy Market Regional Analysis
6.2 North America Enzyme Replacement Therapy Market Revenue 2020-2028 (US$ Million)
6.3 North America Enzyme Replacement Therapy Market Forecast Analysis
7. North America Enzyme Replacement Therapy Market Analysis – by Enzyme Type
7.1 Alglucosidase Alfa
- 7.1.1 Overview
- 7.1.2 Alglucosidase Alfa: North America Enzyme Replacement Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.2 Agalsidase Beta
- 7.2.1 Overview
- 7.2.2 Agalsidase Beta: North America Enzyme Replacement Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.3 Imiglucerase
- 7.3.1 Overview
- 7.3.2 Imiglucerase: North America Enzyme Replacement Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.4 Idursulfase
- 7.4.1 Overview
- 7.4.2 Idursulfase: North America Enzyme Replacement Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.5 Galsulfase
- 7.5.1 Overview
- 7.5.2 Galsulfase: North America Enzyme Replacement Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.6 Velaglucerase Alfa
- 7.6.1 Overview
- 7.6.2 Velaglucerase Alfa: North America Enzyme Replacement Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.7 Other Enzymes
- 7.7.1 Overview
- 7.7.2 Other Enzymes: North America Enzyme Replacement Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
8. North America Enzyme Replacement Therapy Market Analysis – by Therapeutic Conditions
8.1 Gaucher's Disease
- 8.1.1 Overview
- 8.1.2 Gaucher's Disease: North America Enzyme Replacement Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.2 Fabry's Disease
- 8.2.1 Overview
- 8.2.2 Fabry's Disease: North America Enzyme Replacement Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.3 MPS
- 8.3.1 Overview
- 8.3.2 MPS: North America Enzyme Replacement Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.4 Pompe's Disease
- 8.4.1 Overview
- 8.4.2 Pompe's Disease: North America Enzyme Replacement Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.5 SCID
- 8.5.1 Overview
- 8.5.2 SCID: North America Enzyme Replacement Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.6 Other Therapeutic Conditions
- 8.6.1 Overview
- 8.6.2 Other Therapeutic Conditions: North America Enzyme Replacement Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
9. North America Enzyme Replacement Therapy Market Analysis – by Route of Administration
9.1 Parenteral
- 9.1.1 Overview
- 9.1.2 Parenteral: North America Enzyme Replacement Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.2 Oral
- 9.2.1 Overview
- 9.2.2 Oral: North America Enzyme Replacement Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
10. North America Enzyme Replacement Therapy Market Analysis – by End User
10.1 Hospitals
- 10.1.1 Overview
- 10.1.2 Hospitals: North America Enzyme Replacement Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
10.2 Infusion Centers
- 10.2.1 Overview
- 10.2.2 Infusion Centers: North America Enzyme Replacement Therapy Market – Revenue and Forecast, 2020-2028 (US$ Million)
11. North America Enzyme Replacement Therapy Market – North America Analysis
11.1 Overview
11.2 North America
- 11.2.1 North America Enzyme Replacement Therapy Market Breakdown, by Key
Country, 2023 and 2028 (%)
- 11.2.1.1 North America Enzyme Replacement Therapy Market – Revenue and
Forecast Analysis – by Country
- 11.2.1.1 US:
North America Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.1.1 US: North America Enzyme Replacement Therapy Market Breakdown, by Enzyme Type
- 11.2.1.1.2 US: North America Enzyme Replacement Therapy Market Breakdown, by Therapeutic Conditions
- 11.2.1.1.3 US: North America Enzyme Replacement Therapy Market Breakdown, by Route of Administration
- 11.2.1.1.4 US: North America Enzyme Replacement Therapy Market Breakdown, by End User
- 11.2.1.2 Canada:
North America Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.2.1 Canada: North America Enzyme Replacement Therapy Market Breakdown, by Enzyme Type
- 11.2.1.2.2 Canada: North America Enzyme Replacement Therapy Market Breakdown, by Therapeutic Conditions
- 11.2.1.2.3 Canada: North America Enzyme Replacement Therapy Market Breakdown, by Route of Administration
- 11.2.1.2.4 Canada: North America Enzyme Replacement Therapy Market Breakdown, by End User
- 11.2.1.3 Mexico :
North America Enzyme Replacement Therapy Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.3.1 Mexico : North America Enzyme Replacement Therapy Market Breakdown, by Enzyme Type
- 11.2.1.3.2 Mexico : North America Enzyme Replacement Therapy Market Breakdown, by Therapeutic Conditions
- 11.2.1.3.3 Mexico : North America Enzyme Replacement Therapy Market Breakdown, by Route of Administration
- 11.2.1.3.4 Mexico : North America Enzyme Replacement Therapy Market Breakdown, by End User
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Sanofi.
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 BioMarine Pharmaceutical Inc.
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Takeda Pharmaceutical Company Limited.
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 AbbVie Inc.
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Janssen Pharmaceutical ( Johnson & Johnson Services,Inc.).
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Alexion Pharmaceutical, Inc.(AstaZeneca).
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Amicus Therapeutics.
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Recordati S.p.A.
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 CHIESI farmaceutici S.p.A.
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products and Services
- 14.9.4 Financial Overview
- 14.9.5 SWOT Analysis
- 14.9.6 Key Developments
14.10 Pfizer Inc.
- 14.10.1 Key Facts
- 14.10.2 Business Description
- 14.10.3 Products and Services
- 14.10.4 Financial Overview
- 14.10.5 SWOT Analysis
- 14.10.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations
Get Free Sample For North America Enzyme Replacement Therapy Market
